2004
DOI: 10.1016/s0360-3016(04)01813-9
|View full text |Cite
|
Sign up to set email alerts
|

Long-term responses in patients with relapsed or refractory follicular lymphoma treated with yttrium 90 ibritumomab tiuxetan (Zevalin)

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles